Activity Overview
Diabetic microvascular complications (DMC), including retinopathy, nephropathy, and peripheral neuropathy, represent a major cause of morbidity among patients with diabetes. The purpose of this activity is to increase understanding of timely and appropriate screening and diagnostic procedures so that the heavy personal, social, and economic burdens of these conditions may be mitigated.
Release Date: August 2007
Expiration Date: August 31, 2009
Intended Audience
This activity was developed for diabetologists, endocrinologists, primary care physicians, and related diabetes specialists involved in diabetes care.
Method of Participation and Obtaining Continuing Education Credit
The participant should: 1) view the content presented; 2) take the post test; 3) complete and submit the continuing education registration and evaluation forms for credit. This activity should take approximately 75 minutes to complete. The expiration date for this activity is August 31, 2009. No credit will be granted after this date.
Continuing education credit is offered upon successful completion of the post-test. Certificates will be issued to participants approximately 3 to 4 weeks after receipt of both the registration and evaluation forms and successful completion of the post-test with a passing score of 80% or higher.
Learning Objectives
At the conclusion of this activity, the participant should be able to:
- List the signs and symptoms of each of the 3 diabetic microvascular complications (DMC), including diabetic retinopathy, diabetic nephropathy, and diabetic peripheral neuropathy
- Utilize the appropriate scales and diagnostic instruments available for screening patients with diabetes for diabetic peripheral neuropathy
- Apply appropriate screening practices for diabetic retinopathy and macular edema in clinical practice
- Determine the need for referring patients to a specialist, such as an ophthalmologist, based on results from diabetic retinopathy screening
- Employ standard screening and diagnostic tests for identifying patients with early manifestations of diabetic nephropathy
- Differentiate the sensitivity of various routine screening methods for diabetic nephropathy and determine the need for advanced screening
Accreditation Statement for Physicians
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the Center for Accredited Healthcare Education (CAHE), the Institute for Medical and Nursing Education (IMNE), and International Medical Press (IMP). CAHE is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation Statement for Physicians
The Center for Accredited Healthcare Education designates this educational activity for a maximum of 1.25 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Disclosure of Conflicts of Interest
In compliance with Accreditation Council for Continuing Medical Education (ACCME), it is the policy of CAHE and IMNE to ensure fair balance, independence, objectivity, and scientific rigor in all programming. All individuals involved in planning (eg, CME/CE provider staff, faculty, and planners) are expected to disclose any significant financial relationships with commercial interests over the past 12 months. CAHE and IMNE also require that faculty identify and reference off-label product or investigational use of pharmaceutical and medical device products.
All conflicts of interest have been mitigated and resolved through the use of an external peer review process.
AUTHOR
Andrew JM Boulton, MD, DSc (hon), FRCP
Professor of Medicine, Department of Medicine
Manchester Royal Infirmary
Manchester, United Kingdom
Disclosure of Conflicts in Interest: Formal Advisor – Pfizer Inc., Eli Lilly and Company. Speaker’s Bureau- Eli Lilly and Company.
Dr Boulton does not discuss any off-label use of commercial products, nor does he discuss any investigational products.
CME/CE PROVIDER AND EDUCATIONAL PARTNER STAFF
All staff of CAHE, IMNE, and IMP in a position to influence content have filed statements of disclosure with the CME and CE provider. Any conflicts of interest were identified and resolved prior to their involvement in planning this activity. Disclosures are available for review by contacting Steve Weinman at 1 609 936 7015 or e-mail at steve.weinman@cahe.com.
Steve Weinman, RN
Senior Director, CAHE
Conflict of Interest Disclosure: None
Martin Quan, MD
CME Peer- and Conflict of Interest Reviewer
DIrector, Office of CME
David Geffen School of Medicine at UCLA
Conflict of Interest Disclosure: none
Amy Kline
Account Director, IMP
Conflict of Interest Disclosure: None
Joelle Escoffery, PhD
Scientific Director, IMP
Conflict of Interest Disclosure: None
Marge Tamas
Senior Medical Writer, IMP
Conflict of Interest Disclosure: None
Disclaimer
This activity is designed for healthcare professionals for educational purposes. Information and opinions offered by the faculty/presenters represent their own viewpoints. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information.
While the Center for Accredited Healthcare Education and Institute for Medical and Nursing Education make every effort to have accurate information presented, no warranty, expressed or implied, is offered. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
Commercial Support Acknowledgement
This activity is supported by an educational grant from Eli Lilly and Company.
Site Requirements
WINDOWS
- 266 MHz CPU (600MHz recommended)
- Windows 98 or higher
- 64 MB RAM
- 800 x 600 screen resolution, thousands of colors (1024 X 768, millions of colors [32 bit] recommended)
- Browser: Internet Explorer 5.0 or higher; Netscape 4.7, 6.2, or higher
- Plug-ins: Flash, Shockwave, QuickTime, and Chime
- NOTE: Use of Netscape 6.0 is not recommended due to a known incompatibility with the Shockwave plug-in. (You may obtain the current version of these browsers for Windows by clicking on Internet Explorer download or Netscape download , then follow the online instructions.)
MACINTOSH
- 266 MHz CPU
- OS 8.6 or higher
- 64 MB RAM
- 800 x 600 screen resolution, thousands of colors
- Browser:
OS 8-9 : Netscape 4.7, 6.2, or higher (Web only: Internet Explorer 5 or higher)
OS X : Internet Explorer 5.2 or higher; Netscape 6.2 or higher
- Plug-ins: Flash, Shockwave, QuickTime, and Chime
- NOTE: Use of Netscape 6.0 is not recommended due to a known incompatibility with the Shockwave plug-in. (You may obtain the current version of these browsers for Macintosh by clicking on Internet Explorer download or Netscape download , then follow the online instructions.)
ALL COMPUTERS
